Docusate Sodium
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11089 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 18 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | Plummer-Vinson syndrome | KG + DL |
| 2 | vitamin B12- and folate-independent constitutional megaloblastic anemia | KG + DL |
| 3 | bile duct disease | KG + DL |
| 4 | acute urate nephropathy | KG + DL |
| 5 | nephrolithiasis | KG + DL |
| 6 | bile duct neoplasm | KG + DL |
| 7 | biotin metabolic disease | KG + DL |
| 8 | obstructive jaundice | KG + DL |
| 9 | vitamin deficiency disorder | KG + DL |
| 10 | IRIDA syndrome | KG + DL |
| 11 | ariboflavinosis | KG + DL |
| 12 | biliary tract disease | KG + DL |
| 13 | magnesium deficiency | KG + DL |
| 14 | Keshan disease | KG + DL |
| 15 | swayback | KG + DL |
| 16 | choline deficiency disease | KG + DL |
| 17 | potassium deficiency | KG + DL |
| 18 | protein-energy malnutrition | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.